@article{94402, keywords = {Antidiabetic, erythema nodosum leprosum, lepra reaction, pharmacology, stress, targets}, author = {Thangaraju P and Varthya S and Venkatesan S}, title = {Target/therapies for chronic recurrent erythema nodosum leprosum.}, abstract = {

A Type 2 lepra reaction or erythema nodosum leprosum is an anticipated complication in the lepromatous spectrum of leprosy cases. It is an example of an immune complex-mediated complement activated disease (Type III hypersensitivity reaction). Hence, we tried to target the inflammatory mediators and the mental stressors for the possible management strategies.

}, year = {2020}, journal = {Indian journal of pharmacology}, volume = {52}, pages = {222-226}, month = {01/2020}, issn = {1998-3751}, url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446680/}, doi = {10.4103/ijp.IJP_788_19}, language = {eng}, }